Drug class · Oncology & immunology

TNF blockers

Biologics that block tumor necrosis factor, including adalimumab, infliximab, etanercept and their biosimilars.

63 finished products listed with the FDA

Most-listed names in this class

Ranked by the number of FDA listings, which reflects labelers and package variety — not sales or prescribing.

HCPCS references in Med-Code’s directory

FDA-listed products

Finished products in the TNF blockers class, A–Z by brand
ProductStrengthForm · routeLabelerProduct NDC
Amjevitaadalimumab-attoAdalimumab 80 mg/.8mLInjectionSubcutaneousAmgen USA Inc.72511-481
Amjevitaadalimumab-attoAdalimumab 40 mg/.8mLInjectionSubcutaneousAmgen USA Inc.72511-400
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneousAmgen USA Inc.72511-479
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneousAmgen USA Inc.72511-482
Amjevitaadalimumab-attoAdalimumab 20 mg/.2mLInjectionSubcutaneousNuvaila Limited84612-399
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneousNuvaila Limited84612-479
Amjevitaadalimumab-attoAdalimumab 80 mg/.8mLInjectionSubcutaneousNuvaila Limited84612-481
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneousNuvaila Limited84612-482
Amjevitaadalimumab-attoAdalimumab 20 mg/.4mLInjectionSubcutaneousAmgen, Inc55513-411
Amjevitaadalimumab-attoAdalimumab 20 mg/.2mLInjectionSubcutaneousAmgen, Inc55513-399
Amjevitaadalimumab-attoAdalimumab 40 mg/.8mLInjectionSubcutaneousAmgen, Inc55513-400
Amjevitaadalimumab-attoAdalimumab 40 mg/.8mLInjectionSubcutaneousAmgen, Inc55513-410
Amjevitaadalimumab-attoAdalimumab 10 mg/.2mLInjectionSubcutaneousAmgen, Inc55513-413
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneousAmgen, Inc55513-479
Amjevitaadalimumab-attoAdalimumab 80 mg/.8mLInjectionSubcutaneousAmgen, Inc55513-480
Amjevitaadalimumab-attoAdalimumab 80 mg/.8mLInjectionSubcutaneousAmgen, Inc55513-481
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneousAmgen, Inc55513-482
Amjevitaadalimumab-attoAdalimumab 20 mg/.2mLInjectionSubcutaneousAmgen USA Inc.72511-399
Avsolainfliximab-axxqInfliximab 100 mg/10mLInjection, Powder, Lyophilized, For solutionIntravenousAmgen, Inc55513-670
Adalimumabadalimumab-adazAdalimumab 80 mg/.8mLInjection, SolutionSubcutaneousSandoz Inc61314-325
Adalimumabadalimumab-adazAdalimumab 40 mg/.4mLInjection, SolutionSubcutaneousSandoz Inc61314-327
Adalimumabadalimumab-adazAdalimumab 20 mg/.2mLInjection, SolutionSubcutaneousSandoz Inc61314-332
Adalimumabadalimumab-adazAdalimumab 10 mg/.1mLInjection, SolutionSubcutaneousSandoz Inc61314-391
Adalimumab-bwwdAdalimumab 40 mg/.4mLSolutionSubcutaneousCordavis Limited83457-187
Adalimumab-bwwdAdalimumab 40 mg/.4mLSolutionSubcutaneousCordavis Limited83457-186

Med-Code uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in